KBN2201 attenuates the hippocampal astrocytic NOX4-MPO/OPN axis and restores mitochondrial protein markers not recovered by chronic L-DOPA in an MPTP mouse model of Parkinson’s disease
Neurochemistry International · 2026-11 · 106288
DOI: 10.1016/j.neuint.2026.106288 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurochemistry International, 2026-11. Verfasst von Chae Young Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, College of Veterinary Medicine, Konkuk University, Seoul, 05029, Republic of Korea. Die Arbeit nennt 55 Literaturangaben.
Abstract (Originalsprache)
The basis of the hippocampal, non-motor pathology of Parkinson's disease (PD) remains incompletely defined. We previously described an astrocytic axis in the PD hippocampus in which myeloperoxidase (MPO) and osteopontin (OPN) are induced in parallel downstream of NADPH oxidase 4 (NOX4). Here, in male C57BL/6J mice given a chronic (28-day daily) MPTP regimen, we asked whether oral KBN2201 (OPTBA), a hybrid ester of 2-hydroxy-4-trifluoromethyl benzoic acid and pyruvate, is associated with attenuation of this axis. l-DOPA served as a dopaminergic comparator, co-administered throughout the MPTP regimen. The reported behavioral outcomes were obtained seven days after the final dose, before tissue collection. KBN2201 (5 and 20 mg/kg) improved rotarod and grip-strength performance, preserved nigrostriatal tyrosine hydroxylase-positive neurons, and reduced α-synuclein immunoreactivity in the dentate gyrus and the substantia nigra, with a significant reduction in the striatum at 20 mg/kg. In the dentate gyrus, MPTP increased astrocytic NOX4, MPO, and OPN. Hippocampal immunoblotting showed increased levels of 4-hydroxynonenal (4-HNE)-modified protein adducts and reduced levels of the mitochondrial protein-import components TIM23 and TOM20 together with oxidative phosphorylation (OXPHOS) complex subunits I-V. KBN2201 attenuated each change and restored Ki67- and doublecortin (DCX)-positive cell populations. l-DOPA also improved motor performance, reduced 4-HNE-modified protein adducts, MPO, OPN, and α-synuclein in the dentate gyrus, and restored Ki67-positive cells, but did not restore NOX4 protein, TIM23, TOM20, or any OXPHOS subunit, whereas both KBN2201 doses did. Motor improvement can therefore occur without recovery of the hippocampal mitochondrial protein marker profile.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anatomy, College of Veterinary Medicine, Konkuk University, Seoul, 05029, Republic of Korea.
- Preclinical Research Center, Daegu-Gyeongbuk Medical Innovation Foundation (K-MEDI hub), Daegu, 41061, Republic of Korea.
- Department of Medical Science, Soonchunhyang University, Asan, 31538, Republic of Korea.
- Department of Anatomy, College of Veterinary Medicine, Konkuk University, Seoul, 05029, Republic of Korea. Electronic address: admiral@konkuk.ac.kr.
- Department of Pharmacology, Ajou University School of Medicine, Suwon, 16499, Republic of Korea; Efficacy Test Center for Mental & Behavioral Disorders, Ajou University Hospital, Suwon, 16499, Republic of Korea; BK21 R&…
Zitieren
APA
Kim, C. Y., Park, J. S., Jo, M., Choi, S., Ko, K., Yi, S. S., & Lee, S. R. (2026). KBN2201 attenuates the hippocampal astrocytic NOX4-MPO/OPN axis and restores mitochondrial protein markers not recovered by chronic L-DOPA in an MPTP mouse model of Parkinson’s disease. Neurochemistry International, 106288. https://doi.org/10.1016/j.neuint.2026.106288
Vancouver
Kim CY, Park JS, Jo M, Choi S, Ko K, Yi SS, et al. KBN2201 attenuates the hippocampal astrocytic NOX4-MPO/OPN axis and restores mitochondrial protein markers not recovered by chronic L-DOPA in an MPTP mouse model of Parkinson’s disease. Neurochemistry International. 2026:106288. doi:10.1016/j.neuint.2026.106288
BibTeX
@article{Kim2026,
author = {Kim, Chae Young and Park, Joon-Suk and Jo, Miri and Choi, Seohee and Ko, Kayoung and Yi, Sun Shin and Lee, Sang Rae},
title = {KBN2201 attenuates the hippocampal astrocytic NOX4-MPO/OPN axis and restores mitochondrial protein markers not recovered by chronic L-DOPA in an MPTP mouse model of Parkinson’s disease},
journal = {Neurochemistry International},
year = {2026},
pages = {106288},
doi = {10.1016/j.neuint.2026.106288}
}
EUVIMED